Home money EIB grants EUR 15 million loan to Quantum Surgical for commercial launch of Epione®, its medical robot

EIB grants EUR 15 million loan to Quantum Surgical for commercial launch of Epione®, its medical robot

by drbyos
>@Quantum Surgical” src=”https://www.eib.org/photos/download.do?documentId=73df1acc-2600-4446-af13-8faffac3d0ae&binaryType=WM” loading=”lazy”/><figcaption class= ©Quantum Surgical
  • This funding will allow Quantum Surgical to accelerate the clinical adoption of this surgical robot intended for the treatment of liver cancer.
  • The operation is part of a global fundraising of 40 million euros alongside the investment group Ally Bridge specializing in life sciences, Bpifrance and Caisse d’Epagne Languedoc-Roussillon.
  • This investment is being carried out within the framework of the European Guarantee Fund endowed with 25 billion euros in order to support European companies as part of the relaunch of activity after the Covid-19 pandemic.

The European Investment Bank (EIB) and the Montpellier start-up Quantum Surgical specializing in “medtech” have announced the signing of a financing agreement for an amount of 15 million euros. The operation which aims to finance the marketing of the Epione medical robot designed for the minimally invasive treatment of liver cancer is part of a fundraising campaign of 40 million euros in total. Led by the global investment group specializing in life sciences Ally Bridge Group (ABG), through an investment of 20 million euros, it also includes financing from Bpifrance and Caisse d’Epargne Languedoc-Roussillon. This operation brings the total amount of funds raised by Quantum Surgical to 50 million euros since its creation in 2017.

This funding, which follows the CE marking announced last September, will support the company’s operations dedicated to the commercial launch of Epione®, a medical robot designed to help physicians perform percutaneous tumor ablations in the body. abdomen, both safer and more efficient. Epione® aims to enable more patients to benefit from minimally invasive treatment for liver cancer, through a technique of percutaneously inserting a needle to destroy a tumor.

See also  The effect of taxes and the tax credit - El Financiero

“The EIB is pleased to contribute to the development of Quantum Surgical and its innovative technology to improve the treatment of liver cancer. Faced with the ongoing challenges posed by Covid-19, this funding of 15 million euros, with the support of the Pan-European Guarantee Fund (GEF), demonstrates the importance that Europe attaches to supporting innovation and promising technologies in the field of health care, a sector essential for the well-being of populations ”, declared Ambroise Fayolle, Vice-President of the European Investment Bank.

“We are delighted to have closed this financing round and honored with the strong and continued support of our historic investor, Ally Bridge Group, and this from our previous company Medtech SA, prior to its acquisition by Zimmer Biomet in 2016. These additional funds provide us with will help accelerate the clinical adoption of Epione® our medical robot for the treatment of liver cancer, ”said Bertin NAHUM, president and co-founder of Quantum Surgical.

“As an early-stage investor in Quantum Surgical, ABG is proud to continue to support the company’s remarkable achievements during the Covid-19 pandemic, as evidenced by its recent achievement of the CE mark,” said Frank Yu, Founder, CEO of Ally Bridge Group. “We expect Quantum Surgical to achieve important development milestones in the near term, which will allow Epione® to treat more liver cancer patients faster and more effectively than the care currently available. “

General informations

About Quantum Surgical

Quantum Surgical is an innovative medical robotics company that contributes to the development of tomorrow’s healthcare. It aims to facilitate the treatment of cancer by allowing more patients to benefit from innovative, targeted and less invasive treatments.

See also  St. Veiter Investmentbanker donates 10,000 euros to Caritas • KLiCK Kärnten

The Epione® robot developed by Quantum Surgical is a robotic solution designed to help practitioners plan, guide and evaluate percutaneous ablation of tumors located in the abdomen, a technique that involves inserting a needle through the skin up to the tumor to destroy it.

Co-founded in 2017 by Bertin NAHUM, Quantum Surgical is based in Montpellier, France.

AboutAlly Bridge Group

Ally Bridge Group is a global healthcare investment group focused on high impact life science innovation in private and public markets. The company was founded in 2013 by Frank Yu, Managing Director and Chief Investment Officer, and has offices in New York and Hong Kong. Through its scientific and clinical research, as well as its expertise in mergers and acquisitions and capital markets, Ally Bridge Group seeks to seize investment opportunities through the capital structure to meet unmet medical needs. .

Related Videos

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.